635 related articles for article (PubMed ID: 14663654)
1. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.
Kanowski S; Hoerr R
Pharmacopsychiatry; 2003 Nov; 36(6):297-303. PubMed ID: 14663654
[TBL] [Abstract][Full Text] [Related]
2. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R
Pharmacopsychiatry; 1996 Mar; 29(2):47-56. PubMed ID: 8741021
[TBL] [Abstract][Full Text] [Related]
3. A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia.
Le Bars PL; Kieser M; Itil KZ
Dement Geriatr Cogn Disord; 2000; 11(4):230-7. PubMed ID: 10867450
[TBL] [Abstract][Full Text] [Related]
4. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF
JAMA; 1997 Oct 22-29; 278(16):1327-32. PubMed ID: 9343463
[TBL] [Abstract][Full Text] [Related]
5. Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimer's disease.
Le Bars PL; Velasco FM; Ferguson JM; Dessain EC; Kieser M; Hoerr R
Neuropsychobiology; 2002; 45(1):19-26. PubMed ID: 11803237
[TBL] [Abstract][Full Text] [Related]
6. Response patterns of EGb 761 in Alzheimer's disease: influence of neuropsychological profiles.
Le Bars PL
Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S50-5. PubMed ID: 13130389
[TBL] [Abstract][Full Text] [Related]
7. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R
Phytomedicine; 1997 Mar; 4(1):3-13. PubMed ID: 23195239
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of brief infusions with Ginkgo biloba Special Extract EGb 761 in dementia of the vascular and Alzheimer type].
Haase J; Halama P; Hörr R
Z Gerontol Geriatr; 1996; 29(4):302-9. PubMed ID: 8974721
[TBL] [Abstract][Full Text] [Related]
9. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.
Mazza M; Capuano A; Bria P; Mazza S
Eur J Neurol; 2006 Sep; 13(9):981-5. PubMed ID: 16930364
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O;
Int J Geriatr Psychiatry; 2011 Nov; 26(11):1186-94. PubMed ID: 21140383
[TBL] [Abstract][Full Text] [Related]
11. Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial.
Napryeyenko O; Borzenko I;
Arzneimittelforschung; 2007; 57(1):4-11. PubMed ID: 17341003
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type.
Maurer K; Ihl R; Dierks T; Frölich L
J Psychiatr Res; 1997; 31(6):645-55. PubMed ID: 9447569
[TBL] [Abstract][Full Text] [Related]
13. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S
J Psychiatr Res; 2012 Jun; 46(6):716-23. PubMed ID: 22459264
[TBL] [Abstract][Full Text] [Related]
14. Cyclandelate in the treatment of patients with mild to moderate primary degenerative dementia of the Alzheimer type or vascular dementia: experience from a placebo controlled multi-center study.
Weyer G; Eul A; Milde K; Wierich W; Herrmann WM
Pharmacopsychiatry; 2000 May; 33(3):89-97. PubMed ID: 10855459
[TBL] [Abstract][Full Text] [Related]
15. Ginkgo biloba special extract EGb 761 in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trial.
Woelk H; Arnoldt KH; Kieser M; Hoerr R
J Psychiatr Res; 2007 Sep; 41(6):472-80. PubMed ID: 16808927
[TBL] [Abstract][Full Text] [Related]
16. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial.
van Dongen M; van Rossum E; Kessels A; Sielhorst H; Knipschild P
J Clin Epidemiol; 2003 Apr; 56(4):367-76. PubMed ID: 12767414
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N;
Int J Geriatr Psychiatry; 2014 Oct; 29(10):1087-95. PubMed ID: 24633934
[TBL] [Abstract][Full Text] [Related]
18. Ginkgo biloba for cognitive impairment and dementia.
Birks J; Grimley EV; Van Dongen M
Cochrane Database Syst Rev; 2002; (4):CD003120. PubMed ID: 12519586
[TBL] [Abstract][Full Text] [Related]
19. [Delay in progression of dependency and need of care of dementia patients treated with Ginkgo special extract EGb 761].
Haan J; Hörr R
Wien Med Wochenschr; 2004 Nov; 154(21-22):511-4. PubMed ID: 15638069
[TBL] [Abstract][Full Text] [Related]
20. Baseline neuropsychiatric symptoms are effect modifiers in Ginkgo biloba extract (EGb 761®) treatment of dementia with neuropsychiatric features. Retrospective data analyses of a randomized controlled trial.
Ihl R; Tribanek M; Bachinskaya N
J Neurol Sci; 2010 Dec; 299(1-2):184-7. PubMed ID: 20837354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]